DRS LAMBERT & NG — All Prescriptions & Medications — Page 2
Practice Code: A83073 | STANLEY, DH9 7XT
Showing results 51-100 of 544
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Carbamazepine | 952 | 38.4K | £2.8K | +220.8% ▲ |
| Thiamine hydrochloride | 934 | 29.3K | £819 | +77.2% ▲ |
| Ibuprofen | 919 | 94.6K | £4.7K | +80.7% ▲ |
| Senna | 913 | 45.6K | £1.1K | +51.7% ▲ |
| Co-codamol (Codeine phosphate/paracetamol) | 902 | 91.3K | £3.7K | -53.9% ▼ |
| Venlafaxine | 877 | 37.5K | £4.0K | +3.8% ▲ |
| Carbocisteine | 853 | 88.0K | £2.0K | +59.8% ▲ |
| Glucose blood testing reagents | 845 | 69.4K | £8.8K | +7.1% ▲ |
| Diclofenac diethyl | 803 | 86.9K | £9.0K | +126.1% ▲ |
| Atenolol | 792 | 22.9K | £531 | +31.4% ▲ |
| Perindopril erbumine | 779 | 10.6K | £909 | +46.8% ▲ |
| Doxycycline hyclate | 754 | 8,406 | £835 | +47.1% ▲ |
| Esomeprazole | 752 | 19.7K | £1.4K | +85.8% ▲ |
| Montelukast | 739 | 14.7K | £735 | +7.9% ▲ |
| Gliclazide | 734 | 31.2K | £828 | -13.7% ▼ |
| Finasteride | 729 | 13.9K | £535 | +11.3% ▲ |
| Solifenacin | 723 | 14.1K | £856 | +51.5% ▲ |
| Candesartan cilexetil | 706 | 22.7K | £1.2K | -40.5% ▼ |
| 690 | 401.9K | £4.5K | -29.9% ▼ | |
| Lamotrigine | 677 | 20.0K | £1.0K | +14.6% ▲ |
| Donepezil hydrochloride | 658 | 8,916 | £1.7K | +113.2% ▲ |
| Docusate sodium | 652 | 48.8K | £3.3K | +75.9% ▲ |
| Ferrous sulfate | 642 | 15.1K | £620 | +24.9% ▲ |
| 632 | 1,377 | £48.5K | +16.0% ▲ | |
| Rosuvastatin calcium | 626 | 16.7K | £616 | -30.3% ▼ |
| Ezetimibe | 618 | 14.4K | £2.5K | -13.1% ▼ |
| Quinine sulfate | 593 | 11.6K | £1.9K | +104.8% ▲ |
| Alginic acid compound preparations | 590 | 305.2K | £3.8K | +0.7% vs avg |
| Promethazine hydrochloride | 587 | 14.6K | £2.1K | +64.2% ▲ |
| Oxybutynin | 582 | 28.2K | £4.1K | +205.5% ▲ |
| Digoxin | 577 | 9,747 | £746 | +52.5% ▲ |
| 568 | 8,540 | £5.9K | -14.5% ▼ | |
| Bendroflumethiazide | 556 | 15.8K | £272 | -28.1% ▼ |
| Budesonide | 551 | 848 | £22.1K | +1.7% vs avg |
| Cetirizine hydrochloride | 549 | 27.4K | £1.2K | +9.9% ▲ |
| Famotidine | 538 | 14.8K | £8.4K | +10.3% ▲ |
| Levetiracetam | 531 | 27.4K | £3.5K | +16.0% ▲ |
| 520 | 694 | £30.8K | +67.4% ▲ | |
| Sodium valproate | 513 | 50.8K | £3.3K | +61.3% ▲ |
| Insulin aspart | 506 | 3,396 | £22.0K | +32.9% ▲ |
| Mometasone furoate | 502 | 540 | £4.1K | +25.0% ▲ |
| Topiramate | 500 | 21.8K | £3.3K | +181.3% ▲ |
| Hyoscine butylbromide | 491 | 54.2K | £3.8K | +110.7% ▲ |
| Tirzepatide | 474 | 485 | £45.3K | +144.1% ▲ |
| Flucloxacillin sodium | 473 | 23.7K | £1.4K | +5.2% ▲ |
| Eplerenone | 453 | 7,399 | £932 | +70.8% ▲ |
| Rivaroxaban | 452 | 10.0K | £6.8K | -26.1% ▼ |
| Quetiapine | 449 | 10.4K | £5.2K | -27.9% ▼ |
| 445 | 47.9K | £1.4K | +60.9% ▲ | |
| Co-dydramol (Dihydrocodeine/paracetamol) | 435 | 42.8K | £2.3K | +142.1% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.